Todd B Kreutzian

Title: Todd B Kreutzian: Innovator in Oligonucleotide Synthesis

Introduction

Todd B Kreutzian is a notable inventor based in Golden, Colorado. He has made significant contributions to the field of oligonucleotide synthesis, particularly through his innovative patent. His work is instrumental in advancing methods and systems that enhance the efficiency and accuracy of nucleotide extension chain verification.

Latest Patents

Todd B Kreutzian holds a patent for "Nucleotide extension chain verification - Methods and systems for synthesizing an oligonucleotide in a reaction chamber comprising a solid support." This patent describes a process where a nucleotide monomer is selected for addition to an oligonucleotide. The method involves feeding an inlet stream containing the selected monomer into a reaction chamber, where conditions are optimized for oligonucleotide synthesis. The outlet stream from the chamber can be analyzed by mass spectrometry to confirm the identity of the monomer, ensuring the accuracy of the synthesis process.

Career Highlights

Todd is currently employed at Agilent Technologies, Inc., where he continues to work on innovative solutions in the field of biotechnology. His expertise in oligonucleotide synthesis has positioned him as a valuable asset to his team and the company.

Collaborations

Some of Todd's coworkers include Jason Epps and Joseph Guiles, who collaborate with him on various projects within the company.

Conclusion

Todd B Kreutzian's contributions to the field of oligonucleotide synthesis through his patent demonstrate his commitment to innovation and excellence. His work at Agilent Technologies, Inc. continues to influence advancements in biotechnology.